loading...
Cross
Emergent BioSolutions Inc. (EBS:NYSE) Strategic SWOT, PESTLE Analysis and Financial Insight - Assessment of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, Financial and Operational KPI's, and Recent Trends

Report Spotlight

    Emergent BioSolutions Inc. operates as a life sciences company that focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats in the United States. Emergent BioSolutions operates in two key business segments: products and contract development and manufacturing services. Its products segment offers medical countermeasures that address public health threats. Its contract services segment provides drug development and manufacturing services to clients. Emergent BioSolutions offers products and services that address a range of public health threats including chemical, biological, radiological, nuclear, and explosives threats; emerging infectious diseases; travel health issues; public health crises; and acute, emergency, and community care needs. Some of their key products include vaccines for smallpox, anthrax, botulism, and typhoid; treatments for opioid overdose, nerve agent exposure, and cyanide poisoning; and contract development and manufacturing services. Founded in 1998, the company is headquartered in Gaithersburg, Maryland, United States. The report offers a comprehensive and easily accessible overview of the Emergent BioSolutions Inc.'s business operations. It presents all available data in a detailed format, including SWOT and PESTLE Analysis, ESG Spotlight, Financial KPI's & Benchmarking and more. By integrating these strategic analyses, the report provides a comprehensive understanding of the Emergent BioSolutions Inc.'s overall strategic standing. This comprehensive assessment supports informed decision-making, strategic planning, and the development of sustainable business strategies. Key Inclusions in the report:
    • In-depth Emergent BioSolutions Inc. Information:- Deep dive into the internal workings of the company, this section provides unparalleled knowledge and facilitates a comprehensive understanding of the company's key attributes.
    • Emergent BioSolutions Inc.'s Strategic Standing:- The report presents a comprehensive assessment of the Emergent BioSolutions Inc.'s strategic standing, incorporating key elements such as ESG (Environmental, Social, and Governance) spotlight, SWOT and PESTLE Analysis.
      • By analysing these internal factors, the report provides insights into the company's sustainability efforts and its alignment with ethical and responsible business practices, Emergent BioSolutions Inc.'s current standing and areas for strategic focus.
      • By understanding the company's external factors, the report highlights opportunities to enhance efficiency, reduce costs, gain a competitive advantage and on the same time identify potential risks and opportunities arising from the external landscape.
    • Emergent BioSolutions Inc. Financial Analysis:- It outlines key financial ratios related to profitability, margin analysis, asset turnover, credit ratios, market ratios and long-term solvency. This information enhances decision-making processes and investment guidance.
    • Emergent BioSolutions Inc. Competitive Landscape:- It provides a unique analysis of the competitors, along with key insights and business overview. This knowledge helps effectively manage business environment and boost company's business and sales activities by gaining insight into competitors' operations.
    • Emergent BioSolutions Inc.'s Recent News and Deals:- The report includes relevant news and deal activities under taken by the company in very recent time period. This information enhances the awareness of the principal trends in the company's business, organic and inorganic growth perspectives and more.
    Note: This report is made available upon request. You will receive the most up to date version within 3 business days of your purchase, excluding weekends and public holidays.

Key Highlights

Quaintel Research

Scope

  • Tactical Analysis:- Various strategic frameworks to gain insights into a company's competitive position and operational environment. These analytical tools assist in identifying competitive advantages, potential risks, and areas for improvement and efficiency, enabling companies to make informed tactical decisions.
  • Business Strategy:- Contributes to shaping the company's overall direction, goals, and decision-making processes, ensuring long-term success and alignment with stakeholder expectations.
  • Financial Position:- Provide valuable information on the financial performance and investor sentiment surrounding the company. Indicating the level of confidence and expectations in the company's future prospects. These components collectively contribute to understanding the financial health and market perception of the company.
  • Company Fundamentals:- These fundamentals offer valuable insights into the company's history, operations, leadership, and geographical presence, aiding in a comprehensive understanding of the organization.
  • Competitive Landscape:- An identification of the company's main competitors, providing insights into the competitive landscape it operates in.

Reasons to Buy

  • Comprehensive Understanding of the Emergent BioSolutions Inc.'s internal and external factors through SWOT analysis, PESTLE analysis, Value Chain analysis, Financial Analysis, and Competitors Benchmarking.
  • Strive Strategic Decision Making with various analyses and identifying potential customers and suppliers.
  • Mitigate Risk with help of thorough analysis of internal and external factors. Furthermore, develop strategies and contingency plans to address these challenges and minimize their impact on business operations.
  • Competitive Benchmarking will help to gain a competitive advantage by understanding industry trends, customer preferences, and best practices.
  • Financial Performance Evaluation provides crucial insights into key financial ratios and trends, supporting better financial decision-making and resource allocation.
  • Valuable insights from the report enable investors and partners to make informed decisions regarding potential Collaborations, Investments, or Partnerships with the company.
    For additional deep-dive analysis on the company Emergent BioSolutions Inc.:
  • Emergent BioSolutions Inc. Value Chain Analysis - Click Here
  • Emergent BioSolutions Inc. Porter's Five Forces Analysis - Click Here
  • Emergent BioSolutions Inc. VRIO Analysis - Click Here
  • Emergent BioSolutions Inc. BCG Analysis - Click Here
  • Emergent BioSolutions Inc. Segmentation, Targeting and Positioning (STP) Analysis - Click Here
  • Emergent BioSolutions Inc. Ansoff Matrix Analysis - Click Here
  • Emergent BioSolutions Inc. Other Analysis - Click Here

Synopsis

Comprehensive overview of the Emergent BioSolutions Inc.'s business operations. The report presents all available data in a detailed format, including SWOT and PESTLE Analysis, ESG Spotlight, Value Chain Analysis, Financial KPI's & Benchmarking and more. By integrating these strategic analyses, the report provides a comprehensive understanding of the Emergent BioSolutions Inc.'s overall strategic standing. This comprehensive assessment supports informed decision-making, strategic planning, and the development of sustainable business strategies.

Table of Contents

 
    Emergent BioSolutions Inc. Executive Summary Emergent BioSolutions Inc. - Key Company Facts Emergent BioSolutions Inc. - Company Description Emergent BioSolutions Inc. - Top Executives Emergent BioSolutions Inc. - Top Executives Biographies Emergent BioSolutions Inc. - Head Office & Locations
  • Head Office - Country
  • Key Subsidiaries
  • Key Joint Ventures
  • Emergent BioSolutions Inc. - Products and Services
  • Products
  • Services
  • Emergent BioSolutions Inc. - Historic Events Emergent BioSolutions Inc. - Company's Management Discussion Emergent BioSolutions Inc. - Company's Mission and Vision
  • Mission
  • Vision
  • Emergent BioSolutions Inc. - Corporate Strategy Emergent BioSolutions Inc. - Business Description Emergent BioSolutions Inc. - ESG Spotlight
  • Environment
  • Social
  • Corporate Governance
  • Emergent BioSolutions Inc. - SWOT Analysis
  • Overview
  • Strengths
  • Weaknesses
  • Opportunities
  • Threats
  • Emergent BioSolutions Inc. - PESTLE Analysis
  • Overview
  • Political Factors
  • Economic Factors
  • Social Factors
  • Technological Factors
  • Legal Factors
  • Environmental Factors
  • Emergent BioSolutions Inc. - Financial Deep Dive
  • Share Price Trend - (Average Share Closing Price)
  • Summary of Profit and Loss Statement
  • Summary of Balance Sheet
  • Summary of Cash Flow Statement
  • Emergent BioSolutions Inc. Key Financial Ratio Analysis • Activity Ratio Charts • Growth Ratios Charts • Leverage Ratio Charts • Liquidity Ratio Charts • Profitability Ratio Charts
  • Competing Players
  • Snapshot of Competing Players
  • Key Company Facts
  • Company Description
  • Emergent BioSolutions Inc. - Key Deals Emergent BioSolutions Inc. - In the News
    Appendix Definitions Research Methodology Disclaimer Contact Us

List of Tables


Table 1: Emergent BioSolutions Inc. - Company Facts Table 2: Emergent BioSolutions Inc. - Top Executives Table 3: Emergent BioSolutions Inc. - Top Executives Biographies Table 4: Emergent BioSolutions Inc. - Subsidiaries Table 5: Emergent BioSolutions Inc. - Key Joint Ventures Table 6: Emergent BioSolutions Inc. - Products Table 7: Emergent BioSolutions Inc. - Services Table 8: Emergent BioSolutions Inc. - Historic Events Table 9: Emergent BioSolutions Inc. - Share Price Trend Table 10: Emergent BioSolutions Inc. - Ratio Analysis Table 11: Emergent BioSolutions Inc. - Competing Players

List of Figures


Figure 1: Emergent BioSolutions Inc. - Head Office - Country Figure 2: Emergent BioSolutions Inc. - Key Subsidiaries Figure 3: Emergent BioSolutions Inc. - SWOT Analysis Figure 4: Emergent BioSolutions Inc. - PESTLE Analysis Figure 5: Emergent BioSolutions Inc. - Average Share Price Trend Figure 6: Emergent BioSolutions Inc. - Profit and Loss Statement Figure 7: Emergent BioSolutions Inc. - Balance Sheet Figure 8: Emergent BioSolutions Inc. - Cash Flow Statement Figure 9: Emergent BioSolutions Inc. - Activity Ratio Charts Figure 10: Emergent BioSolutions Inc. - Growth Ratio Charts Figure 11: Emergent BioSolutions Inc. - Leverage Ratio Charts Figure 12: Emergent BioSolutions Inc. - Liquidity Ratio Charts Figure 13: Emergent BioSolutions Inc. - Profitability Ratio Charts Figure 14: Competing Players - Key Financials *Note: We have made every effort to include all sections as highlighted above, but we may have omitted some due to data availability.

Request a Report

Email This Page to a colleague

Recipient #1
Recipient #2
Recipient #3
Recipient #4
Recipient #5

FAQ’s and Related Details

Emergent BioSolutions Inc. is headquartered in United States, North America.

Emergent BioSolutions Inc. is a Public company, listed on New York Stock Exchange and trading under the symbol EBS.

Emergent BioSolutions Inc. primarily operates in Pharmaceuticals & Healthcare industry.

Apart from analyzing the core fundamentals of the company which includes company’s business portfolio (Products, Services, Brands, Business Operations Spread), Historical Drive, Corporate Strategy, Top Executives etc., Quaintel Research also does analyses and provide Key Financial Ratios (Activity, Growth, Leverage, Liquidity, Market And Profitability Ratios) (for public company), ESG Spotlight (Environmental, Social, and Corporate Governance), Recent Business Investment Trends and the following Strategic Analysis (covering both Internal and External factors) on request.
  • Emergent BioSolutions Inc. SWOT Analysis (Strengths, Weaknesses, Opportunities, Threats) - Click Here
  • Emergent BioSolutions Inc. PESTLE Analysis (Political, Economic, Social, Technological, Legal and Environmental) - Click Here
  • Emergent BioSolutions Inc. Value Chain Analysis - Click Here
  • Emergent BioSolutions Inc. Porter's Five Forces Analysis - Click Here
  • Emergent BioSolutions Inc. VRIO Analysis (Value, Rarity, Imitability, and Organization) - Click Here
  • Emergent BioSolutions Inc. BCG Analysis - Click Here
  • Emergent BioSolutions Inc. STP Analysis (Segmentation, Targeting and Positioning) - Click Here
  • Emergent BioSolutions Inc. Ansoff Matrix Analysis - Click Here
  • Emergent BioSolutions Inc. Other Analysis - Click Here

Quaintel’s Research Methodology is based on industry best practices approved by leading research, consulting, and advisory firms. The research methodology follows a combination of exhaustive secondary research and primary research, which involves market experts from leading companies across the value chain. Some of the key sources referred to while building the report are (wherever applicable):
  • Statutory Fillings (10K, 20-F, 10-Q, Annual Reports, Management Notes & Interviews)
  • Company Website
  • In-house Databases
  • Media Release
  • Investors Presentations
In addition, Quaintel’s research methodology leverages a proprietary predictive analytics platform to provide a highly accurate and unbiased company intelligence across global markets.
Want to speak to us directly?

Contact us on live chat or fill out a form with your enquiry

© Quaintel, All rights reserved | Privacy Policy

Designed & Developed by Cross Atlantic